Mankind became the first Indian and second global company to develop a dydrogesterone containing drug for treatment of pregnancy-related complications
It has recently ventured into the US market with the filing of 12-15 ANDAs every year
The company's initial focus will be Uttar Pradesh followed by Uttarakhand, Bihar, and North-East